Michael K Liu
College of Letters & Science, University of California, Berkeley, USAPublications
-
Research
Chlorhexidine as a Therapeutic Agent for COVID-19 Infection
Author(s): Y Hanna Huang, Michael K Liu and Jong T Huang
Background: We previously documented that 0.12% chlorhexidine oral rinse and oropharyngeal spray could eliminate oropharyngeal SARS-CoV-2 which might prevent COVID-19 infection and also prevent SARS-CoV-2 spread from a patient to other people. We currently further investigated such application of chlorhexidine might also decrease mortality of COVID-19 infection. Methods: We reviewed electronic medical records on patients we previously did study for chlorhexidine to eliminate oropharyngeal SARS-CoV-2 and determine whether chlorhexidine treatment influencing the mortality rate. We also repeated the same study in different period of COVID-19 infection to further confirm the efficiency of chlorhexidine in the management of COVID-19 infection. 0.12% of chlorhexidine was given oral rinse plus oropharyngeal spray for the initial 4 days of hospitali.. Read More»